CS
SGFY

Candriam SCA’s Signify Health, Inc. SGFY Stock Holding History

Candriam SCA’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-32,601
Closed -$934K – 945
2022
Q4 		$934K Hold
32,601
– – 0.01% 708
2022
Q3 		$950K Buy
+32,601
New +$751K 0.01% 718

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Candriam SCA's SGFY Position: Q1 2023 in Review

Candriam SCA sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 32,601 shares — an estimated $934K sold.

Candriam SCA first reported a position in SGFY in Q3 2022 and held it in 2 quarters. The position peaked at $950K in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Candriam SCA reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 32,601 Signify Health, Inc. shares in Q1 2023, an estimated $934K.
  • Candriam SCA first reported a position in Signify Health, Inc. in Q3 2022 and held it in 2 quarters.
  • Candriam SCA's Signify Health, Inc. position peaked at $950K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.